Costs of inducible defence along a resource gradient.

by Christer Brönmark, Thomas Lakowitz, P Anders Nilsson, Johan Ahlgren, Charlotte Lennartsdotter, Johan Hollander
Published 2012-01-01

Breast cancer, sickness absence, income and marital status. A study on life situation 1 year prior diagnosis compared to 3 and 5 years after diagnosis.

by Sonja Eaker, Annette Wigertz, Paul C Lambert, Leif Bergkvist, Johan Ahlgren, Mats Lambe, Uppsala/Örebro Breast Cancer Group
Published 2011-01-01

Aromatase inhibitors use and risk for cardiovascular disease in breast cancer patients: A population-based cohort study

by Maria Sund, Miguel Garcia-Argibay, Hans Garmo, Johan Ahlgren, Anna-Karin Wennstig, Irma Fredriksson, Henrik Lindman, Antonis Valachis
Published 2021-10-01

Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial

by Jana de Boniface, Jan Frisell, Yvette Andersson, Leif Bergkvist, Johan Ahlgren, Lisa Rydén, Roger Olofsson Bagge, Malin Sund, Hemming Johansson, Dan Lundstedt, on behalf of the SENOMAC Trialists’ Group
Published 2017-05-01